Acquisition of Star 26 Capital Inc. by Nukkleus Inc.
The owner, status and timeline of this project. A free account opens every field.
Source: Stock Titan
Nukkleus Inc. acquired a 51% controlling stake in Star 26 Capital Inc., which owns 95% of RIMON, a supplier of components for Israel's Iron Dome missile defense system. This acquisition marks Nukkleus's strategic shift towards the defense sector and aims to capitalize on growing defense investments.
- Status
- Closed
- Sector
- Aerospace & Defense, Metal, Steel
- Location
- Israel
- Updated
- 22 Jul 2026
- Source
- Stock Titan
ConstructChat
Ask ConstructChat about Acquisition of Star 26 Capital Inc. by Nukkleus Inc.
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | Completed |
Taiyo status | Closed |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | Nukkleus Inc. acquired a 51% controlling stake in Star 26 Capital Inc., which owns 95% of RIMON, a supplier of components for Israel's Iron Dome missile defense system. This acquisition marks Nukkleus's strategic shift towards the defense sector and aims to capitalize on growing defense investments. |
Original sector | Defense |
Budget |
Location
Country | Israel |
Source
Source | Stock Titan |
URL |
More Details
Record type | Project |
Sector | Aerospace & Defense, Metal, Steel |
Article published date | 2025-05-26 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
More Aerospace & Defense projects in Israel
- Control Over Noisy Communication Media
- Auto-tuning, manipulation and braiding of topological quantum bits in tapered nanowire networks
- Molecular Mechanisms for Construction of Protective Mucus Hydrogels
- The eco-evolutionary costs and benefits of CRISPR-Cas systems, and their effect on genome diversity within populations
- Safety Mechanisms for Artificial General Intelligence (AGI)
- Deciphering Split Monopoiesis Impact on Tissue Macrophages
- Next Generation Cockpit HUD Integration
- Harnessing CRISPR-Cas technology for sustainable antibiotic resistance markers
